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Nearly complete resonance assignment and the high-resolution NMR structure
of the acyl-carrier protein from Borrelia burgdorferi, a target of the Seattle
Structural Genomics Center for Infectious Disease (SSGCID) structure-
determination pipeline, are reported. This protein was chosen as a potential
target for drug-discovery efforts because of its involvement in fatty-acid
biosynthesis, an essential metabolic pathway, in bacteria. It was possible to
assign >98% of backbone resonances and >92% of side-chain resonances using
multidimensional NMR spectroscopy. The NMR structure was determined to a
backbone r.m.s.d. of 0.4 A ˚ and contained four  -helices and two 310-helices. A
structure-homology search revealed that this protein is highly similar to the acyl-
carrier protein from Aquifex aeolicus.
1. Biological context
Borrelia burgdorferi is a Gram-negative bacterium and a cause of
Lyme disease. It was isolated and cultured in the 1980s and was
named after its discoverer (Burgdorfer et al., 1982). Its complete
genome sequence was reported in the late 1990s (Fraser et al., 1997)
and provided clues to the role of different genes in the pathogenesis,
prevention and treatment of Lyme disease (Guidoboni et al., 2006).
Interestingly, this pathogenic bacterium can survive without iron and
this property appears to be an important factor in its survival. We
selected an acyl-carrier protein, BobuA.00658.a, from B. burgdorferi
for structure determination within the SSGCID pipeline. This protein
is important in fatty-acid biosynthesis. Because of considerable
mechanistic and structural differences from the same processes in
eukaryotes, enzymes in this pathway represent attractive anti-
bacterial targets. The acyl-carrier protein is a universal and highly
conserved carrier of acyl intermediates during fatty-acid biosynthesis.
In yeast, these proteins exist as separate domains within a large
multifunctional fatty-acid syntheses polyprotein, whereas in bacteria
they are mostly monomeric proteins. These proteins are also cofac-
tors of various primary and secondary pathways, including signaling
and production of natural bioactive products. For these reasons, these
proteins are interesting drug targets for novel antibacterials and a
structure was pursued within SSGCID.
The structures of several acyl-carrier proteins from different
organisms have been reported. However, no acyl-carrier protein has
been studied from B. burgdorferi. In this manuscript, we report
almost complete resonance assignment and the high-resolution NMR
structure of the acyl-carrier protein from B. burgdorferi.
2. Methods and experiments
2.1. Cloning, protein overexpression and sample preparation
The gene coding for the acyl-carrier protein (UniProt ID O51647;
entry name ACP_BORBU) was ampliﬁed from the genomic DNA of
B. burgdorferi using standard PCR techniques. The protein will also
be referred to as BobuA.00658.a, its SSGCID identiﬁer. The ampli-
ﬁed product was cloned into pET-AVA vector, a modiﬁed pET28
vector. The expression construct was transformed into RosettaEscherichia coli. Cells were initially grown at 310 K in M9 minimal
medium containing 0.05%
15NH4Cl and 0.2%
13C-glucose (Isotec).
After reaching an OD600 of 0.4–0.5, the temperature was lowered to
295 K and the cells were induced at an OD600 of 0.6–0.7 by the
addition of 0.2 mM isopropyl  -d-1-thiogalactopyranoside (IPTG)
for 16–18 h. The protein was puriﬁed using an Ni–NTA column
followed by Protease 3C cleavage and gel ﬁltration. The protein
eluted as a single peak corresponding to a monomer and was
conﬁrmed by SDS–PAGE to be >95% pure. The fractions from
the gel ﬁltration containing protein were pooled, concentrated
and quantitated by absorption at 280 nm using an absorbance
"280 = 2980 M
 1 cm
 1. The ﬁnal NMR sample contained  1.4 mM
protein, 100 mM KCl, 20 mM potassium phosphate pH 7.0 in 93%
H2O plus 7%
2H2O or in 99.9%
2H2O for other experiments.
2.2. NMR experiments
All NMR experiments were conducted at 298 Kon Bruker Avance
500 MHz, Bruker Avance 600 MHz and Varian 800 MHz spectro-
meters equipped with triple-resonance cryoprobes and pulse
ﬁeld gradients. Experiments recorded on BobuA.00658.a include
sensitivity-enhanced 2D [
15N–
1H]-HSQC, 3D HNCO, HNCA,
HN(CO)CA, CBCACONH, CBCANH, 3D
15N-edited TOCSY-
HSQC (mixing time 68 ms) and
15N/
13C-edited NOESY-HSQC
(mixing times 60 and 120 ms). We also recorded a 2D GFT HNHA
(Barnwal et al., 2007). The data were processed with NMRPipe
(Delaglio et al., 1995) and/or TopSpin v.2.1 and were analyzed using
CcpNmr (Vranken et al., 2005). Proton chemical shifts were cali-
brated relative to 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) at
298 K (0.000 p.p.m.). Carbon and nitrogen chemical shifts were cali-
brated indirectly from DSS.
2.3. Distance constraints for structure calculations (NOE-derived
distance constraints)
Cross-peaks from 3D [
1H–
1H]-NOESY-[(
15N–
1H)/(
13C–
1H)]-
HSQC and 2D [
1H–
1H]-NOESY spectra were integrated to obtain
distance constraints. The calibration of cross-peaks was performed
using the macro within CYANA with the minimum distance set to
2.4 A ˚ and the maximum distance set to 6.2 A ˚ . Cross-peaks in the
NOESY spectra were classiﬁed based on their intensities as 1.8–2.7 A ˚
(strong), 1.8–3.7 A ˚ (medium), 1.8–5.0 A ˚ (weak) or 1.8–6.2 A ˚ (very
weak). GFT (3,2)D HNHA (Barnwal et al., 2007) was used to accu-
rately measure
3J(H
N—H
 ). Hydrogen-bond constraints were only
added for residues that are involved in  -helices as characterized
by initial structures and based on the protection observed in H/D-
exchange experiments at a later stage of structure calculation. An
upper limit of 2.0 A ˚ was used for the H—O distance in all hydrogen
bonds. A total of 1113 distance constraints (an average of  15
constraints per residue), which include 345 intraresidue, 308 inter-
residue (sequential), 245 medium-range and 177 long-range distance
constraints and 38 hydrogen-bonding constraints were used in the
structure calculations of BobuA.00658.a (Table 1).
2.4. Dihedral angle constraints
Dihedral angle constraints were generated from the measured
3J(H
N—H
 ) (Barnwal et al., 2007) and by TALOS
+ (Shen et al., 2009).
A total of 120 (’ and  ) dihedral angle constrains were used in
structure calculation (Table 1).
2.5. Structure calculations
Structure calculations were executed using CYANA2.1 (Gu ¨ntert,
2004). The standard simulated-annealing protocol was used with
10 000 torsion-angle dynamics (TAD) steps. Each round of structure
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Table 1
NMR structural statistics for BobuA.00658.a.
Residues 8–82 were used in the Ramachandran statistics as the N-terminal residues are
unstructured.
NMR distance and dihedral constraints
Distance constraints
Total NOE 1113
Intraresidue (|i   j| = 0) 345
Interresidue
Sequential (|i   j| = 1) 308
Medium range (1 < |i   j| < 5) 245
Long range (|i   j|   5) 177
Other (hydrogen-bond constraints) 38
Dihedral angle constraints
’ ( )6 0
  ( )6 0
Constraint violations
NOE distance violations (>0.1 A ˚ ) None
van der Waals violations (>0.1 A ˚ )1
Dihedral angle violations (>3 ) None
Average target function (A ˚ 2) 1.28   0.09
Average r.m.s. deviation (A ˚ )
Backbone atom (8–82) 0.42   0.11
Heavy atom (8–82) 0.93   0.13
Ramachandran plot statistics (%)
Residues in most favored regions 81.0
Residues in additional allowed regions 16.9
Residues in generously allowed regions 2.1
Residues in disallowed regions 0.0
Structure-quality factors: overall statistics.
Mean score SD Z score†
PROCHECK G factor‡ (’,   only)  0.36 N/A  1.10
PROCHECK G factor‡ (all dihedral angles)  0.66 N/A  3.90
Verify3D 0.19 0.0215  4.33
ProSA II ( ve) 0.24 0.0483  1.70
MolProbity clash score 30.66 3.0089  3.74
† With respect to mean and standard deviation for for a set of 252 X-ray structures of
<500 residues with resolution   1.80 A ˚ , R factor   0.25 and Rfree   0.28; a positive value
indicates a ‘better’ score. (Generated using PSVS 1.3.) ‡ Residues with sum of ’ and  
order parameters >1.8. Ordered residue range 7–83. (Generated using PSVS 1.3.)
Figure 1
2D [
15N–
1H]-HSQC spectrum of BobuA.00658.a recorded at pH 7.0and 298 K. The
spectrum was recorded on a Bruker Avance 600 MHz spectrometer with 1024 and
128 complex points along the t2 and t1 dimensions, respectively. The protein
concentration was 1.4 mM in 93% H2O/7%
2H2O. The peaks are labeled with the
single-letter amino-acid code followed by their respective sequence number, as
established by sequence-speciﬁc assignments of the protein backbone.calculations started with 100 randomized conformers. Of all the
energy-minimized calculated structures, the 20 structures with the
lowest residual target function values were chosen for further
analyses. All-atom pairwise r.m.s.d.s were also computed using
CYANA2.1 (Gu ¨ntert, 2004) and MOLMOL (Koradi et al., 1996). The
quality of the structures was evaluated using PROCHECK
(Laskowski et al., 1996) and the PSVS 1.3 web server (Bhattacharya et
al., 2007). The structure was deposited in the PDB under code 2kwl.
3. Result and discussion
3.1. NMR assignments and data deposition
The BobuA.00658.a protein is free of Cys, His and Trp residues. We
could assign  98% of observable backbone resonances and >92% of
observable side-chain resonances using triple-resonance experiments
as described in x2. The
1H
N and
15N resonance assignments for the
protein are shown by the single-letter code followed by the sequence
number in the [
15N–
1H]-HSQC (Fig. 1). The three NH resonances
(Arg34, Ile61 and Glu70) are shifted downﬁeld owing to their
involvement in hydrogen bonding. These residues may have a func-
tional role in catalysis, but we have not investigated this role using
site-directed mutagenesis. A clearer picture in terms of function and
its relation to these residues would require further biochemical
experiments. The missing backbone amide resonances consist of two
residues in the N-terminal region of the protein which are broadened
beyond detection. The information about the
1H,
13C and
15N reso-
nance assignments thus obtained for the protein has been deposited
in the BMRB under accession code 16856.
3.2. NMR solution structure of BobuA.00658.a
The NMR structure of BobuA.00658.a was determined using
distance constraints and dihedral constraints as detailed in Table 1.
Fig. 2 shows the ensemble of 20 superimposed structures derived
using CYANA. The quality of the structure was veriﬁed with
PROCHECK (Laskowski et al., 1996), which revealed that none of
the residues lie in disallowed regions of the Ramachandran plot. The
structural and Ramachandran statistics for BobuA.00658.a are also
provided in Table 1. The polypeptide segments consisting of residues
7–22, 34–37, 43–57 and 72–83 form four  -helices, whereas segments
structural communications
Acta Cryst. (2011). F67, 1137–1140 Barnwal & Varani   Acyl-carrier protein 1139
Figure 2
NMR structure of BobuA.00658.a. (a) Ensemble of 20 superimposed low-energy NMR-derived structures of the protein (backbone r.m.s.d. = 0.43   0.11 A ˚ ) in ribbon
representation. (b) Cartoon representation; important residues in the hydrophobic core are shown in purple color with their respective sequence number. Images were
generated using PyMOL (http://www.pymol.org).
Figure 3
Sequence alignment of the acyl-carrier protein from B. burgdorferi compared with related acyl-carrier proteins from different prokaryotic organisms: S. thermophilum,
A. aeolicus, P. marinus and C. thermocellum. The alignment was produced using ESPript 2.2 (http://espript.ibcp.fr/ESPript/ESPript/). Residues with high sequence similarity
and identity are shown in closed boxes and as colored regions, respectively. The secondary structures from PDB entry 2kwl are shown at the top of the ﬁgure.26–28 and 65–68 form 310-helices. Within the inner face of the helices,
several hydrophobic side chains form the core of the protein (Fig. 2b).
Sequence alignment with the enzymes from Symbiobacterium
thermophilum, Aquifex aeolicus, Prochlorococcus marinus and
Clostridium thermocellum revealed that BobuA.00658.a has 48%
sequence similarity to the enzyme from S. thermophilum, 44% to that
from A. aeolicus, 52% to that from P. marinus and 58% to that from
C. thermocellum (Fig. 3). A structural homology search using
the DALI server (http://ekhidna.biocenter.helsinki.ﬁ/dali_server)
revealed that this protein has 37% similarity to the acyl-carrier
protein from A. aeolicus, which is structurally closest to it. The
backbone r.m.s.d. between the structures from A. aeolicus and
B. burgdorferi was 3.1 A ˚ , whereas alignments of BobuA.00658.a with
structures from other organisms had higher values. Only residues 8–
82 of BobuA.00658.a were selected for r.m.s.d. comparison. Based on
the UniProt and homology search, Ser39 seems to be a central
residue involved in fatty-acid binding. This residue is close to the core
involving three downﬁeld-shifted residues (Arg34, Ile61 and Glu70).
Finally, a proper study including mutation in vivo will provide a
clearer picture regarding fatty-acid binding.
4. Conclusions
We report here the structure of an acyl-carrier protein from
B. burgdorferi. Since this protein was selected as a potential target for
drug-discovery efforts (Myler et al., 2009; Younger & Orsher, 2010)
owing to its involvement in fatty-acid biosynthesis, its structural and
dynamic features could be used to better understand its acyl-carrier
activity and to discover inhibitors of its essential function. This
information could be of value in discovering small-molecule inhibi-
tors for this activity, which could be used in the treatment of Lyme
disease.
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